Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

Feb 9, 2026 3:59:30 PM EST

1.02USD+8.416%(+0.08)193,916

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 9, 2026 8:11:30 AM EST

0.9100USD-3.181%(-0.0299)500

After-hours

Feb 9, 2026 4:51:30 PM EST

1.03USD+1.070%(+0.01)975

Overview HistoricalExchangesShortsMore

open chart

Market Cap

33.74M

Industry

Biotechnology

Next Earnings

Mar 25, 2026 (42d)

NRSN Stats

Avg. Vol. 10 Day

140,488

Avg. Vol. 30 Day

254,474

Employees

Market Cap

33,741,983

Shares Out.

33,112,839

On/Off Exchange

44%/56%

6 Month Beta

0.73

1 Year Beta

0.51

2 Year Beta

0.65

3 Year Beta

0.61

52 Week Low

0.68

52 Week High

2.60

SMA50

0.94

SMA200

1.30

1 Week

+9.59%

1 Month

-4.77%

3 Month

+7.83%

6 Month

-19.13%

1 Year

-9.82%

2 Year

-21.62%

5 Year

-74.78%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $1.02, and today's volume is 193,916. NRSN is up 8.416% today. The 30 day average volume is 254,474. NRSN market cap is 33.74M with 33,112,839 shares outstanding.

.dark-mode .YbRRb9{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .YbRRb9{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ